Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis

• Hauptverfasser: Hong Wang (VerfasserIn), Zhuang Zhuang (VerfasserIn), Yue-Yue Huang (VerfasserIn), Zhi-Zhi Zhuang (VerfasserIn), Yi Jin (VerfasserIn), Han-Yang Ye (VerfasserIn), Xiao-Ji Lin (VerfasserIn), Qun Zheng (VerfasserIn), Yi-Luan Wang (VerfasserIn)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2020-06-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Astragaloside IV (AS-IV) has a variety of biological activities and is widely used to treat kidney diseases. We conducted a systematic review of 24 animal studies including 424 animals to evaluate the efficacy of AS-IV for diabetic nephropathy (DN); all current possible mechanisms were summarized. A...